Hemp Industry: FDA’s CBD Regs Will Chart Direction Of Hemp Market

By Beth Wang
July 26, 2019 at 1:32 PM
Hemp farmers, producers, manufacturers and processors, including those in tribal communities, told a Senate panel they are eagerly awaiting FDA’s next move on regulating cannabis-based products, namely those containing cannabidiol (CBD) derived from hemp, as those regulatory steps will drive the market. FDA Principal Deputy Commissioner Amy Abernethy outlined the challenges FDA faces in crafting a regulatory framework and pathway for CBD derived from hemp at a Senate agriculture committee hearing Thursday (July 25). One of FDA’s main tasks is...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.